Back to GABELLI FUNDS LLC GABELLI FUNDS LLC

TKCTKC
Showing 8 of 30 quarters

Position history for GABELLI FUNDS LLCGABELLI FUNDS LLC's holdings in TURKCELL ILETISIM HIZMET-ADR

GABELLI FUNDS LLC holds 405,500 shares of TKC (TURKCELL ILETISIM HIZMET-ADR), worth $2.4M as of 2026-Q2. TKC represents 0.0% of GABELLI FUNDS LLC's portfolio.

Current Value

$2.4M

Current Shares

405,500

Total Value Change

-$560,300

Total Shares Change

-22,500

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Unchanged
405,500
0.0%
$2.4M0.0%$5.88
0
2026-Q1
Unchanged
405,500
0.0%
$2.4M0.0%$6.58
0
2025-Q4
Unchanged
405,500
0.0%
$2.2M0.0%$5.52
0
2025-Q3
Unchanged
405,500
0.0%
$2.4M0.0%$5.95
0
2025-Q2
Decreased
405,500
-0.1%
$2.5M0.0%$5.67
0
2025-Q1
Unchanged
406,000
0.0%
$2.5M0.0%$6.10
0
2024-Q4
Decreased
406,000
-5.1%
$2.6M0.0%$6.44
0
2024-Q3
Unchanged
428,000
0.0%
$2.9M0.0%$6.46
0

Other major holders of TKC: MORGAN STANLEY

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used